Cargando…
Evaluation of anti-tumorigenic activity of BP3B against colon cancer with patient-derived tumor xenograft model
BACKGROUND: KIOM-CRC#BP3B (BP3B) is a novel herbal prescription that is composed of three plant extracts. Our preliminary study identified that BP3B exhibited potent anti-proliferative activity against various types of cancer cell lines in vitro. Because the in vivo anti-tumor effect of BP3B is not...
Autores principales: | Kim, Hye-Youn, Kim, Jinhee, Ha Thi, Huyen Trang, Bang, Ok-Sun, Lee, Won-Suk, Hong, Suntaek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116142/ https://www.ncbi.nlm.nih.gov/pubmed/27863496 http://dx.doi.org/10.1186/s12906-016-1447-8 |
Ejemplares similares
-
Protein Tyrosine Phosphatase N2 Is a Positive Regulator of Lipopolysaccharide Signaling in Raw264.7 Cell through Derepression of Src Tyrosine Kinase
por: Ha Thi, Huyen Trang, et al.
Publicado: (2016) -
Genomic Profiling of Patient-Derived Colon Cancer Xenograft Models
por: Lee, Won-Suk, et al.
Publicado: (2014) -
MicroRNA-130a modulates a radiosensitivity of rectal cancer by targeting SOX4()()
por: Ha Thi, Huyen Trang, et al.
Publicado: (2019) -
Inflammasome as a Therapeutic Target for Cancer Prevention and Treatment
por: Thi, Huyen Trang Ha, et al.
Publicado: (2017) -
Pellino 3 promotes the colitis‐associated colorectal cancer through suppression of IRF4‐mediated negative regulation of TLR4 signalling
por: Kim, Young‐Mi, et al.
Publicado: (2023)